Extended-spectrum resistance to β-lactams/β-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Extended-spectrum resistance to β-lactams/β-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-08-21
DOI
10.1093/jac/dkz393
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extensive Gene Amplification as a Mechanism for Piperacillin-Tazobactam Resistance in Escherichia coli
- (2018) Lisa M. Schechter et al. mBio
- Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance
- (2018) Patrick N. A. Harris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pharmacokinetics of piperacillin-tazobactam in plasma, peritoneal fluid and peritoneum of surgery patients, and dosing considerations based on site-specific pharmacodynamic target attainment
- (2017) Naoki Murao et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets
- (2016) Sudhir Kumar et al. MOLECULAR BIOLOGY AND EVOLUTION
- β-Lactams and β-Lactamase Inhibitors: An Overview
- (2016) Karen Bush et al. Cold Spring Harbor Perspectives in Medicine
- Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI)
- (2015) Joseph Solomkin et al. CLINICAL INFECTIOUS DISEASES
- Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project
- (2015) Mercedes Delgado-Valverde et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Impact of the MIC of Piperacillin-Tazobactam on the Outcome of Patients with Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli
- (2013) Pilar Retamar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EvolView, an online tool for visualizing, annotating and managing phylogenetic trees
- (2012) Huangkai Zhang et al. NUCLEIC ACIDS RESEARCH
- Selection of Resistant Bacteria at Very Low Antibiotic Concentrations
- (2011) Erik Gullberg et al. PLoS Pathogens
- Clinical Characteristics of Bloodstream Infections Due to Ampicillin-Sulbactam-Resistant, Non-Extended- Spectrum-β-Lactamase-ProducingEscherichia coliand the Role of TEM-1 Hyperproduction
- (2010) Rebecca I. Waltner-Toews et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Three Decades of -Lactamase Inhibitors
- (2010) S. M. Drawz et al. CLINICAL MICROBIOLOGY REVIEWS
- Diagnosis and Management of Complicated Intra‐abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
- (2009) Joseph S. Solomkin et al. CLINICAL INFECTIOUS DISEASES
- AmpC -Lactamases
- (2009) G. A. Jacoby CLINICAL MICROBIOLOGY REVIEWS
- Piperacillin penetration into tissue of critically ill patients with sepsis—Bolus versus continuous administration?
- (2009) Jason A. Roberts et al. CRITICAL CARE MEDICINE
- Contribution of Gene Amplification to Evolution of Increased Antibiotic Resistance in Salmonella typhimurium
- (2009) Song Sun et al. GENETICS
- IRT and CMT β-lactamases and inhibitor resistance
- (2008) R. Cantón et al. CLINICAL MICROBIOLOGY AND INFECTION
- The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria
- (2008) Jean-Marie Pagès et al. NATURE REVIEWS MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now